CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
San Diego, California, United States and 72 other locations
This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...
Phase 3
San Diego, California, United States and 65 other locations
with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a durat...
Phase 3
La Jolla, California, United States and 118 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Chula Vista, California, United States and 208 other locations
in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...
Phase 3
Carlsbad, California, United States and 34 other locations
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...
Phase 3
Carlsbad, California, United States and 30 other locations
It is an open label study to evaluate safety, tolerability and brain microglia response in participants with ALS following multiple doses of...
Phase 2
La Jolla, California, United States and 8 other locations
This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose...
Phase 3
Carlsbad, California, United States and 125 other locations
The ALSpire Study is a clinical trial evaluating the investigational drug BIIB105 in adults living with amyotrophic lateral sclerosis (ALS)....
Phase 1, Phase 2
La Jolla, California, United States and 16 other locations
A Phase I Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis to demonstrate safety & effi...
Phase 1
San Diego, California, United States
Clinical trials
Research sites
Resources
Legal